We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $22.7B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.19%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Healthcare 14.77%
3 Financials 11.9%
4 Industrials 11.05%
5 Consumer Discretionary 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMW
26
DELISTED
VMware, Inc
VMW
$108M 0.61%
1,479,014
+147,883
+11% +$10.4M
PFE icon
27
Pfizer
PFE
$158B
$108M 0.61%
3,371,218
-47,450
-1% -$1.59M
V icon
28
Visa
V
$686B
$108M 0.61%
1,306,498
+199,995
+18% +$16M
AMAT icon
29
Applied Materials
AMAT
$372B
$107M 0.61%
3,562,841
+274,872
+8% +$7.67M
ITW icon
30
Illinois Tool Works
ITW
$75.2B
$101M 0.57%
844,415
-9,173
-1% -$1.06M
LOW icon
31
Lowe's Companies
LOW
$111B
$99.3M 0.56%
1,375,838
+266,145
+24% +$20.7M
APH icon
32
Amphenol
APH
$201B
$95.8M 0.54%
11,811,664
+3,273,944
+38% +$24.9M
GOOG icon
33
Alphabet (Google) Class C
GOOG
$4.02T
$95.2M 0.54%
2,448,780
+301,760
+14% +$11.5M
META icon
34
Meta Platforms (Facebook)
META
$1.67T
$94.8M 0.53%
738,778
+118,045
+19% +$14.7M
WFC icon
35
Wells Fargo
WFC
$271B
$92.4M 0.52%
2,086,569
+391,686
+23% +$18.7M
TMO icon
36
Thermo Fisher Scientific
TMO
$224B
$92.3M 0.52%
580,118
+166,391
+40% +$25.6M
VZ icon
37
Verizon
VZ
$207B
$91.3M 0.51%
1,756,932
-334,970
-16% -$18M
KR icon
38
Kroger
KR
$34.6B
$90.1M 0.51%
3,037,356
+782,054
+35% +$26M
GE icon
39
GE Aerospace
GE
$338B
$87.9M 0.5%
619,109
-2,691
-0.4% -$401K
MCK icon
40
McKesson
MCK
$104B
$86.4M 0.49%
517,886
+443,631
+597% +$82.7M
ABBV icon
41
AbbVie
ABBV
$443B
$85M 0.48%
1,347,465
-72,265
-5% -$4.68M
WAT icon
42
Waters Corp
WAT
$39.8B
$81.7M 0.46%
515,250
+17,489
+4% +$2.71M
PAYX icon
43
Paychex
PAYX
$40.8B
$81.4M 0.46%
1,407,227
+154,993
+12% +$9.29M
DD
44
DELISTED
Du Pont De Nemours E I
DD
$76.8M 0.43%
1,147,034
-6,537
-0.6% -$444K
SPG icon
45
Simon Property Group
SPG
$66.2B
$76.5M 0.43%
369,515
+42,743
+13% +$9.27M
FL
46
DELISTED
Foot Locker
FL
$75.7M 0.43%
1,117,503
+83,994
+8% +$5.24M
ESRX
47
DELISTED
Express Scripts Holding Company
ESRX
$74.7M 0.42%
1,059,091
-189,890
-15% -$14.2M
FFIV icon
48
F5
FFIV
$22.9B
$73M 0.41%
585,793
+28,800
+5% +$3.5M
AVY icon
49
Avery Dennison
AVY
$12.9B
$73M 0.41%
938,286
+72,062
+8% +$5.5M
LLY icon
50
Eli Lilly
LLY
$1T
$72.7M 0.41%
906,292
-21,087
-2% -$1.69M

Similar funds

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.